Suppr超能文献

基于片段的基质金属蛋白酶-13 吲哚抑制剂的发现。

Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.

机构信息

Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877-0368, United States.

出版信息

J Med Chem. 2011 Dec 8;54(23):8174-87. doi: 10.1021/jm201129m. Epub 2011 Nov 9.

Abstract

Matrix metalloproteases (MMPs) play an important role in cartilage homeostasis under both normal and inflamed disease states and, thus, have become attractive targets for the treatment of arthritic diseases. Herein, we describe the identification of a potent, selective MMP-13 inhibitor, developed using fragment-based structure-guided lead identification and optimization techniques. Virtual screening methods identified a novel, indole-based MMP-13 inhibitor that bound into the S1' pocket of the protein exhibiting a novel interaction pattern hitherto not observed in MMP-13 inhibitors. X-ray crystallographic structures were used to guide the elaboration of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over nine other MMP isoforms tested.

摘要

基质金属蛋白酶(MMPs)在正常和炎症疾病状态下的软骨动态平衡中发挥着重要作用,因此,它们已成为治疗关节炎疾病的有吸引力的靶标。在此,我们描述了一种使用基于片段的结构引导的先导识别和优化技术开发的强效、选择性 MMP-13 抑制剂的鉴定。虚拟筛选方法鉴定出一种新型吲哚基 MMP-13 抑制剂,该抑制剂结合到蛋白质的 S1'口袋中,表现出迄今为止在 MMP-13 抑制剂中未观察到的新型相互作用模式。X 射线晶体结构用于指导片段的阐述,最终导致一种强效抑制剂,对测试的其他 9 种 MMP 同工型具有 >100 倍的选择性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验